|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
1/9/2013 7:58:25 AM
Vaccine developer Medicago’s latest contract means local jobs. That’s according to Mike Wanner, executive vice president of operations for Medicago. He took a few minutes to tell me why the contract, for potential future production with the U.S. Department of Defense, isn’t just good news for Medicago — it’s good news for Durham. In short, the contract means Medicago can now bid for Defense Advanced Research Projects Agency (DARPA) projects. “The U.S. Government has needs for a large number of proteins, vaccines or pharmaceutical agents, so we fully expect that there will be solicitations soon,” he says, adding that the feds indicated solicitations could come as early as February, meaning there’s a strong possibility the local headcount would grow. “Depending on the size of the order, we would very likely need to staff up to meet the demands of it,” he says. “Of course, we don’t know that until we get the specific requirements.”
|
|
|
|
|
|
|
|
|
|
|